Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 39,043 | 41,295 | 36,889 | 31,501 | 14,118 |
| Cost of Goods | 584 | 961 | 513 | 377 | 135 |
| Gross Profit | 38,459 | 40,334 | 36,376 | 31,124 | 13,983 |
| Operating Expenses | 110,407 | 100,668 | 95,200 | 83,537 | 87,570 |
| Operating Income | -71,364 | -59,373 | -58,311 | -52,036 | -73,452 |
| Interest Expense | 3,689 | 2,922 | 2,291 | 2,282 | 2,314 |
| Other Income | 246 | 489 | 721 | 1,478 | 2,740 |
| Pre-tax Income | -74,807 | -61,806 | -59,881 | -52,840 | -73,026 |
| Income Tax | 123 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -74,930 | -61,806 | -59,881 | -52,840 | -73,026 |
| Net Income | $-74,930 | $-61,806 | $-59,881 | $-52,840 | $-73,026 |
| EPS Basic Total Ops | -1.21 | -1.01 | -0.97 | -0.86 | -1.20 |
| EPS Basic Continuous Ops | -1.21 | -1.00 | -0.97 | -0.86 | -1.20 |
| EPS Diluted Total Ops | -1.21 | -1.01 | -0.97 | -0.86 | -1.20 |
| EPS Diluted Continuous Ops | -1.21 | -1.00 | -0.97 | -0.86 | -1.20 |
| EPS Diluted Before Non-Recurring Items | -1.21 | -1.00 | N/A | N/A | N/A |
| EBITDA(a) | $-69,248 | $-56,294 | $-56,544 | $-48,770 | $-70,622 |